• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Store » March 2005 – The CenterWatch Monthly : PDF
March 2005 – The CenterWatch Monthly : PDF

March 2005 – The CenterWatch Monthly : PDF

$79.00

Product Details

South Africa: An Important Gateway

Perceived mainly as a good place to conduct HIV trials and rescue trials, South Africa has been working toward projecting a more well-rounded image—that of a country with first-class research infrastructure, an ideal mix of first- and third-world disease patterns and a first-rate regulatory body. Growth of the clinical trials industry in South Africa stems from recent legislative changes, a favorable exchange rate, wider public awareness about clinical trials and the need for doctors to find alternative revenue streams. Underlying it all is the production of consistent quality data. Further growth should result from South Africa’s role as a gateway to the rest of Africa.

Proactive Investigators Talking up Recruitment Success

Patient recruitment is the leading bottleneck in the clinical development process, so more principal investigators are responding to enrollment inefficiencies by becoming proactive and personally recruiting patients. This hands-on approach to patient recruitment may be a successful single-pronged approach for some busy PIs. All sites can benefit from having an active PI as part of a multi-pronged patient recruitment campaign.

Portugal Set for Trial Patient Growth

Implementation of Directive 2001/20/EC has been delayed in Portugal even though the law was passed there last summer.

Eye on: Prostate Cancer

Prostate cancer will result in more than 30,000 deaths in the United States in 2005. CenterWatch has identified a pipeline of 51 drugs in development for prostate cancer.

  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell or Share My Data

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing